Alzheimers

    By Sheryl Nance-Nash

    | 5:05PM 7/29/2011
    Genworth Financial's Cost of Care survey tracked average prices of home care, assisted living facilities and nursing homes across the country, and unsurprisingly, found staggering variations. The priciest state for nursing home care in the U.S. averages more than four times as much as the cheapest.

    By Selena Maranjian, The Motley Fool

    | 9:00AM 7/12/2011
    For children, excursions with grandmother are an adventure. As time passes, however, the ride into the golden years can get bumpy; if you're financially unprepared, it can take a dramatic turn for the worse, and even drive you and your family into bankruptcy. Here are some steps you can take to prevent that.

    By Melly Alazraki

    | 10:00PM 12/01/2010
    Medical imaging and diagnostics powerhouse GE Healthcare teams up with pharmaceutical giant Johnson & Johnson to research methods of detecting Alzheimer's in patients -- even before they begin to exhibit symptoms of the devastating disease.

    By Jennie L. Phipps

    | 1:00PM 11/23/2010
    Alzheimer's is the scariest disease of them all. Slowly losing your sight or your hearing is bad, but relentlessly losing your mind is terrifying. It's also expensive. The cost of caring for people with dementia exceeds $725 billion annually, the combined 2009 revenues of Wal-Mart and Exxon Mobil,...

    By Melly Alazraki

    | 3:56PM 11/02/2010
    Despite earlier studies that hinted that Omega-3 supplements -- commonly sold as fish oil capsules -- might help slow the progression of Alzheimer's disease, a study published Tuesday in the Journal of the American Medical Association shows absolutely no benefit for most patients.

    By Melly Alazraki

    | 10:30AM 9/21/2010
    Its total worldwide costs for 2010 are estimated to be $604 billion, or around 1% of the world's GDP, according to World Alzheimer Report 2010 from Alzheimer's Disease International. By 2030, that burden could hit more than $1.1 trillion.

    By Melly Alazraki

    | 1:38PM 8/17/2010
    Eli Lilly has halted the development of an Alzheimer's treatment after studies showed the experimental drug not only failed to slow the disease's progression, it actually reduced patients' cognition.

    By Martha C. White

    | 10:00AM 8/10/2010
    Radical new thinking in the field of Alzheimer's study holds out the hope that literally millions of Baby Boomers could be diagnosed and possibly treated before the disease's devastation takes effect. While this is good news for middle-aged Americans, it's even better news for certain...

    By Aaron Crowe

    | 6:00PM 6/16/2010
    Former White House reporter Helen Thomas' rant against Israel was more than a "senior moment," but the forced retirement of the 89-year-old is a lesson in what the future of the American workforce could look like. Not that more elderly workers will be telling people where to live in a racist...

    By Melly Alazraki

    | 3:00PM 6/13/2010
    Alzheimer's has been a tough area for medical research, resulting in little help to date for the millions of sufferers. But a new database of patient information from failed trials, built by competing drugmakers, may yield clues to a treatment breakthrough.